Harrow (HROW) News Today → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free HROW Stock Alerts $17.73 -0.44 (-2.42%) (As of 04:02 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 10 at 4:31 AM | marketbeat.comStifel Financial Corp Buys 91,881 Shares of Harrow, Inc. (NASDAQ:HROW)Stifel Financial Corp grew its stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 27.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 431,973 shares of the company's stock after acquiringJune 8 at 2:28 AM | americanbankingnews.comHead to Head Analysis: Harrow (NASDAQ:HROW) & Renovaro (NASDAQ:RENB)June 7 at 6:30 AM | investorplace.comThe Top 7 Growth Stocks to Buy and Hold Until 2030June 5, 2024 | businesswire.comHarrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension StudyJune 5, 2024 | americanbankingnews.comHarrow (NASDAQ:HROW) PT Raised to $25.00June 4, 2024 | americanbankingnews.comHarrow (NASDAQ:HROW) Price Target Increased to $25.00 by Analysts at Lake Street CapitalJune 3, 2024 | marketbeat.comHarrow, Inc. (NASDAQ:HROW) Short Interest Down 9.5% in MayHarrow, Inc. (NASDAQ:HROW - Get Free Report) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 4,980,000 shares, a decrease of 9.5% from the April 30th total of 5,500,000 shares. Based on an average daily volume of 510,400 shares, the days-to-cover ratio is currently 9.8 days.June 3, 2024 | marketbeat.comLake Street Capital Increases Harrow (NASDAQ:HROW) Price Target to $25.00Lake Street Capital upped their price objective on shares of Harrow from $20.00 to $25.00 and gave the company a "buy" rating in a research note on Monday.June 2, 2024 | marketbeat.comFranklin Resources Inc. Boosts Stake in Harrow, Inc. (NASDAQ:HROW)Franklin Resources Inc. raised its position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 27.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 294,221 shares of the company's stock after acquiJune 1, 2024 | marketbeat.comInvictus Private Wealth LLC Cuts Holdings in Harrow, Inc. (NASDAQ:HROW)Invictus Private Wealth LLC reduced its position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 94.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,000 shares of the companMay 29, 2024 | marketbeat.comHarrow (NASDAQ:HROW) Shares Down 5.8% Harrow (NASDAQ:HROW) Trading Down 5.8%May 28, 2024 | insidertrades.com3 Stocks Insiders are Buying That Should be on Your Radar (HROW)May 23, 2024 | marketbeat.comHarrow (NASDAQ:HROW) Trading Up 3.5%Harrow (NASDAQ:HROW) Stock Price Up 3.5%May 17, 2024 | marketbeat.comHarrow, Inc. (NASDAQ:HROW) Sees Large Drop in Short InterestHarrow, Inc. (NASDAQ:HROW - Get Free Report) was the recipient of a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 5,500,000 shares, a drop of 7.1% from the April 15th total of 5,920,000 shares. Based on an average daily volume of 462,100 shares, the days-to-cover ratio is currently 11.9 days.May 17, 2024 | marketbeat.comHarrow (NASDAQ:HROW) Trading Up 5.9%Harrow (NASDAQ:HROW) Trading 5.9% HigherMay 16, 2024 | marketbeat.comQ2 2024 EPS Estimates for Harrow, Inc. Decreased by B. Riley (NASDAQ:HROW)Harrow, Inc. (NASDAQ:HROW - Free Report) - Research analysts at B. Riley lowered their Q2 2024 earnings per share estimates for shares of Harrow in a research note issued to investors on Tuesday, May 14th. B. Riley analyst M. Mamtani now anticipates that the company will post earnings per share oMay 15, 2024 | marketbeat.comCraig Hallum Increases Harrow (NASDAQ:HROW) Price Target to $26.00Craig Hallum upped their price target on Harrow from $24.00 to $26.00 and gave the stock a "buy" rating in a research note on Wednesday.May 15, 2024 | insidermonkey.comHarrow Health, Inc. (NASDAQ:HROW) Q1 2024 Earnings Call TranscriptMay 15, 2024 | marketbeat.comHarrow (NASDAQ:HROW) Earns "Buy" Rating from B. RileyB. Riley reissued a "buy" rating and set a $29.00 price objective (up previously from $26.00) on shares of Harrow in a research report on Wednesday.May 15, 2024 | marketbeat.comEquities Analysts Set Expectations for Harrow, Inc.'s Q4 2024 Earnings (NASDAQ:HROW)Harrow, Inc. (NASDAQ:HROW - Free Report) - Equities researchers at B. Riley increased their Q4 2024 earnings estimates for Harrow in a research note issued to investors on Tuesday, May 14th. B. Riley analyst M. Mamtani now expects that the company will earn $0.17 per share for the quarter, up froMay 15, 2024 | businesswire.comHarrow to Present at Two Investor Conferences in MayMay 15, 2024 | finance.yahoo.comHarrow Inc (HROW) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic AdvancesMay 15, 2024 | finance.yahoo.comHarrow, Inc. (HROW) Stock Price, News, Quote & History - Yahoo FinanceMay 15, 2024 | markets.businessinsider.comHarrow Health’s Promising Growth Trajectory and Strong Financial Outlook Reinforce Buy RatingMay 14, 2024 | marketbeat.comHarrow (NASDAQ:HROW) Shares Gap Up to $12.07Harrow (NASDAQ:HROW) Shares Gap Up to $12.07May 14, 2024 | seekingalpha.comHarrow, Inc. 2024 Q1 - Results - Earnings Call PresentationMay 13, 2024 | investorplace.comHROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q1 2024May 13, 2024 | markets.businessinsider.comCraig-Hallum Keeps Their Buy Rating on Harrow Health (HROW)May 13, 2024 | businesswire.comHarrow Announces First Quarter 2024 Financial ResultsMay 13, 2024 | businesswire.comHarrow Names Greg DiPasquale as Senior Vice President, Head of CommercialMay 10, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Rapid Micro Biosystems (RPID), COMPASS Pathways (CMPS) and Harrow Health (HROW)May 6, 2024 | marketbeat.comHarrow Health (HROW) Scheduled to Post Quarterly Earnings on MondayHarrow Health (NASDAQ:HROW) will be releasing earnings after the market closes on Monday, May 13, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=589316)May 2, 2024 | seekingalpha.comHarrow: Merits A Buy On Sales PotentialMay 2, 2024 | seekingalpha.comHarrow: The Bull Thesis Is On Track, But Short-Term Challenges LoomApril 26, 2024 | insidertrades.comHarrow Health, Inc. (NASDAQ:HROW) Major Shareholder Purchases $199,400.00 in StockApril 25, 2024 | marketbeat.comInsider Buying: Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Buys 20,000 Shares of StockHarrow Health, Inc. (NASDAQ:HROW - Get Free Report) major shareholder Opaleye Management Inc. purchased 20,000 shares of the stock in a transaction on Thursday, April 25th. The stock was acquired at an average price of $9.97 per share, with a total value of $199,400.00. Following the acquisition, the insider now directly owns 3,815,000 shares in the company, valued at $38,035,550. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.April 25, 2024 | businesswire.comHarrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024April 25, 2024 | insidertrades.comOpaleye Management Inc. Purchases 11,715 Shares of Harrow Health, Inc. (NASDAQ:HROW) StockApril 24, 2024 | marketbeat.comHarrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Purchases 11,715 SharesHarrow Health, Inc. (NASDAQ:HROW - Get Free Report) major shareholder Opaleye Management Inc. bought 11,715 shares of Harrow Health stock in a transaction dated Tuesday, April 23rd. The stock was acquired at an average cost of $10.29 per share, for a total transaction of $120,547.35. Following the completion of the transaction, the insider now directly owns 3,786,715 shares in the company, valued at $38,965,297.35. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.April 21, 2024 | insidertrades.comOpaleye Management Inc. Acquires 29,400 Shares of Harrow Health, Inc. (NASDAQ:HROW) StockApril 20, 2024 | finance.yahoo.comHarrow, Inc. (HROW)April 19, 2024 | marketbeat.comInsider Buying: Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Purchases 29,400 Shares of StockHarrow Health, Inc. (NASDAQ:HROW - Get Free Report) major shareholder Opaleye Management Inc. bought 29,400 shares of Harrow Health stock in a transaction dated Friday, April 19th. The stock was purchased at an average price of $10.56 per share, with a total value of $310,464.00. Following the purchase, the insider now directly owns 3,775,000 shares in the company, valued at approximately $39,864,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.April 13, 2024 | marketbeat.comVanguard Group Inc. Has $25.29 Million Stock Holdings in Harrow Health, Inc. (NASDAQ:HROW)Vanguard Group Inc. raised its stake in Harrow Health, Inc. (NASDAQ:HROW - Free Report) by 5.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,759,879 shares of the company's stock after buying an additional 95,389 shares during the quaApril 11, 2024 | marketbeat.comHarrow Health (NASDAQ:HROW) Now Covered by Craig HallumCraig Hallum assumed coverage on Harrow Health in a research note on Thursday. They issued a "buy" rating and a $24.00 price objective for the company.April 3, 2024 | bizjournals.comMelt Pharmaceuticals raises $24 million for drug developmentApril 2, 2024 | finance.yahoo.comMelt Pharmaceuticals Closes $24 Million Series B Preferred Stock FinancingMarch 29, 2024 | insidertrades.comOpaleye Management Inc. Acquires 50,000 Shares of Harrow Health, Inc. (NASDAQ:HROW) StockMarch 28, 2024 | marketbeat.comHarrow Health, Inc. (NASDAQ:HROW) Major Shareholder Purchases $641,000.00 in StockHarrow Health, Inc. (NASDAQ:HROW - Get Free Report) major shareholder Opaleye Management Inc. purchased 50,000 shares of the business's stock in a transaction dated Thursday, March 28th. The shares were acquired at an average cost of $12.82 per share, for a total transaction of $641,000.00. Following the acquisition, the insider now owns 3,745,600 shares of the company's stock, valued at approximately $48,018,592. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Major shareholders that own at least 10% of a company's stock are required to disclose their sales and purchases with the SEC.March 26, 2024 | insidertrades.comMark L. Baum Acquires 9,000 Shares of Harrow Health, Inc. (NASDAQ:HROW) StockMarch 25, 2024 | marketbeat.comInsider Buying: Harrow Health, Inc. (NASDAQ:HROW) CEO Acquires 9,000 Shares of StockHarrow Health, Inc. (NASDAQ:HROW - Get Free Report) CEO Mark L. Baum purchased 9,000 shares of the company's stock in a transaction that occurred on Friday, March 22nd. The stock was acquired at an average price of $11.59 per share, for a total transaction of $104,310.00. Following the purchase, the chief executive officer now owns 2,137,525 shares in the company, valued at approximately $24,773,914.75. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Email Address Top 5 Tech Stocks to Buy for 2024 (Ad)The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution… Click below for your free report "Top 5 Tech Stocks to Buy in 2024", HROW Media Mentions By Week HROW Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HROW News Sentiment▼0.770.76▲Average Medical News Sentiment HROW News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HROW Articles This Week▼72▲HROW Articles Average Week Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LifeVantage News Geron News Rhythm Pharmaceuticals News Bausch Health Companies News Deciphera Pharmaceuticals News Vera Therapeutics News Maravai LifeSciences News Amphastar Pharmaceuticals News Amneal Pharmaceuticals News Rocket Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HROW) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored